Bone Mineral Density
Mostrando 13-24 de 406 artigos, teses e dissertações.
-
13. Association between handgrip strength and bone mass parameters in HIV-infected children and adolescents. A cross-sectional study
ABSTRACT BACKGROUND: Low bone mineral content (BMC) and bone mineral density (BMD) have been identified in human immunodeficiency virus (HIV)-infected children and adolescents. The direct adverse effects of HIV infection and combined antiretroviral therapy (ART) negatively contribute to bone metabolism. A direct relationship between muscle strength levels a
Sao Paulo Med. J.. Publicado em: 2021-08
-
14. Association between fractures and traditional risk factors for osteoporosis and low bone mineral density in patients with obesity
ABSTRACT Objective: To evaluate the reasons for request of bone mineral density (BMD) evaluation and correlate the BMD results with previous fractures, risk factors for osteoporosis, and clinical characteristics in patients with obesity. Subjects and methods: Cross-sectional, retrospective, single-site study including adult patients with body mass index (B
Arch. Endocrinol. Metab.. Publicado em: 2021-04
-
15. Metabolic bone disease in children and adolescent patients with ulcerative colitis
Abstract Objective: Metabolic bone disease concerns a broad spectrum of conditions related to reduced bone density. Metabolic bone disease has been linked to chronic inflammatory diseases, such as ulcerative colitis. This study examines the prevalence of metabolic bone disease in ulcerative colitis patients and explores possible clinical predictors. Method
J. Pediatr. (Rio J.). Publicado em: 2021-04
-
16. A practical contemporary approach to decision-making on subclinical hypothyroidism
ABSTRACT Subclinical hypothyroidism (Shypo) is an increasingly frequent condition in common medical practice. Its diagnosis continues to pose a challenge since a series of non-thyroidal and temporary conditions can elevate serum TSH levels. In addition, the consequences of Shypo are still up for debate. Although detrimental cardiovascular effects have been c
Arch. Endocrinol. Metab.. Publicado em: 2021-02
-
17. Hypovitaminosis D, Low Bone Mineral Density, and Diabetes Mellitus as Probable Risk Factors for Benign Paroxysmal Positional Vertigo in the Elderly
Abstract Introduction Studies have found that elderly patients with benign paroxysmal positional vertigo (BPPV) may present low levels of vitamin D (25 (OH) D), changes in bone mineral density, and diabetes mellitus (DM). Objective To investigate the possible association between BPPV, bone mineral density, hypovitaminosis D, 25 (OH) D and DM. Methods The
Int. Arch. Otorhinolaryngol.. Publicado em: 2020-09
-
18. Special emphasis on bone health management in prostate cancer patients: a prospective longitudinal study
ABSTRACT Introduction: Use of androgen deprivation therapy (ADT) in carcinoma prostate (CaP) has deleterious effect on bone mineral density (BMD) leading to increase incidence of osteoporosis and skeletal-related events. We evaluated bone health status and impact of bone-directed therapy (BDT) and ADT on BMD in these patients from Jan 2015-Dec 2018. Materi
Int. braz j urol.. Publicado em: 2020-06
-
19. Prader-Willi syndrome: endocrine manifestations and management
ABSTRACT Prader-Willi syndrome (PWS) is a genetic disorder caused by the absence of gene expression in the 15q11.2-q13 paternal chromosome. Patients with PWS develop hypothalamic dysfunction that can lead to various endocrine changes such as: obesity, growth hormone deficiency, hypogonadism, hypothyroidism, adrenal insufficiency and low bone mineral density.
Arch. Endocrinol. Metab.. Publicado em: 2020-06
-
20. Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis
ABSTRACT Prader-Willi syndrome (PWS) is a genetic disorder caused by the absence of gene expression in the 15q11.2-q13 paternal chromosome. Patients with PWS develop hypothalamic dysfunction that can lead to various endocrine changes such as: obesity, growth hormone deficiency, hypogonadism, hypothyroidism, adrenal insufficiency and low bone mineral density.
Arch. Endocrinol. Metab.. Publicado em: 2020-06
-
21. Reduced bone mineral content and density in neurofibromatosis type 1 and its association with nutrient intake
RESUMO INTRODUÇÃO A Neurofibromatose tipo 1 (NF1) é uma doença genética autossômica dominante caracterizada por envolvimento neurocutâneo e multissistêmico, incluindo baixa densidade mineral óssea (DMO). OBJETIVOS Avaliar características ósseas em indivíduos com NF1 e verificar associação com a ingestão de nutrientes. METODOLOGIA 26 adul
Rev. Assoc. Med. Bras.. Publicado em: 2020-05
-
22. Beneficial effects of Cuscuta chinensis extract on glucocorticoid-induced osteoporosis through modulation of RANKL/OPG signals
Cuscuta chinensis Lam. (Convolvulaceae) is an important herbal medicine widely used to improve sexual function, treat osteoporosis, and prevent aging, and has been reported to exhibit anti-osteoporotic effects in vitro. However, the activity of Cuscuta chinensis Lam. on glucocorticoid-induced osteoporosis still remains unclear. The present study aimed to ass
Braz J Med Biol Res. Publicado em: 05/12/2019
-
23. Probiotic Administration Increases Mandibular Bone Mineral Density on Rats Exposed to Cigarette Smoke Inhalation
Resumo O tabagismo é um dos principais fatores de risco para a doença periodontal, aumentando sua prevalência e gravidade. Os probióticos surgiram como uma alternativa para a prevenção e tratamento de muitas doenças, uma vez que podem modular a resposta imune do hospedeiro e promover a modificação do microbioma. Dessa forma, o objetivo do presente e
Braz. Dent. J.. Publicado em: 28/11/2019
-
24. Impact of calcium aluminate cement with additives on dental pulp-derived cells
Abstract Calcium aluminate cement (CAC) has been highlighted as a promising alternative for endodontic use aiming at periapical tissue repair. However, its effects on dental pulp cells have been poorly explored. Objective: This study assessed the impact of calcium chloride (CaCl2) and bismuth oxide (Bi2O3) or zinc oxide (ZnO) additives on odontoblast cell re
J. Appl. Oral Sci.. Publicado em: 28/11/2019